{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:27:25Z","timestamp":1784089645721,"version":"3.55.0"},"reference-count":47,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Investigation into the role of vitamin C in the prevention and treatment of pneumonia and sepsis has been underway for many decades. This research has laid a strong foundation for translation of these findings into patients with severe coronavirus disease (COVID-19). Research has indicated that patients with pneumonia and sepsis have low vitamin C status and elevated oxidative stress. Administration of vitamin C to patients with pneumonia can decrease the severity and duration of the disease. Critically ill patients with sepsis require intravenous administration of gram amounts of the vitamin to normalize plasma levels, an intervention that some studies suggest reduces mortality. The vitamin has pleiotropic physiological functions, many of which are relevant to COVID-19. These include its antioxidant, anti-inflammatory, antithrombotic and immuno-modulatory functions. Preliminary observational studies indicate low vitamin C status in critically ill patients with COVID-19. There are currently a number of randomized controlled trials (RCTs) registered globally that are assessing intravenous vitamin C monotherapy in patients with COVID-19. Since hypovitaminosis C and deficiency are common in low\u2013middle-income settings, and many of the risk factors for vitamin C deficiency overlap with COVID-19 risk factors, it is possible that trials carried out in populations with chronic hypovitaminosis C may show greater efficacy. This is particularly relevant for the global research effort since COVID-19 is disproportionately affecting low\u2013middle-income countries and low-income groups globally. One small trial from China has finished early and the findings are currently under peer review. There was significantly decreased mortality in the more severely ill patients who received vitamin C intervention. The upcoming findings from the larger RCTs currently underway will provide more definitive evidence. Optimization of the intervention protocols in future trials, e.g., earlier and sustained administration, is warranted to potentially improve its efficacy. Due to the excellent safety profile, low cost, and potential for rapid upscaling of production, administration of vitamin C to patients with hypovitaminosis C and severe respiratory infections, e.g., COVID-19, appears warranted.<\/jats:p>","DOI":"10.3390\/nu12113286","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T09:22:45Z","timestamp":1603790565000},"page":"3286","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["The Emerging Role of Vitamin C in the Prevention and Treatment of COVID-19"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5890-2977","authenticated-orcid":false,"given":"Anitra C.","family":"Carr","sequence":"first","affiliation":[{"name":"Nutrition in Medicine Research Group, Department of Pathology &amp; Biomedical Science, University of Otago, Christchurch 8011, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Rowe","sequence":"additional","affiliation":[{"name":"Intensive Care Department, Newham University Hospital, Barts NHS Trust, London E13 8SL, UK"},{"name":"Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/ajcn\/63.5.760","article-title":"Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients","volume":"63","author":"Schorah","year":"1996","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0891-5849(95)02022-5","article-title":"Ascorbyl radical formation in patients with sepsis: Effect of ascorbate loading","volume":"20","author":"Galley","year":"1996","journal-title":"Free Radic. Biol. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00003246-199603000-00006","article-title":"Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk","volume":"24","author":"Borrelli","year":"1996","journal-title":"Crit. Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-4804(02)00083-5","article-title":"Ascorbic acid dynamics in the seriously ill and injured","volume":"109","author":"Long","year":"2003","journal-title":"J. Surg. Res."},{"key":"ref_5","first-page":"1368","article-title":"Vitamin-C pharmacokinetics in critically ill patients: A randomized trial of four intravenous regimens","volume":"153","author":"Zandvliet","year":"2018","journal-title":"Chest"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13054-017-1891-y","article-title":"Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes","volume":"21","author":"Carr","year":"2017","journal-title":"Crit. Care"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1479-5876-12-32","article-title":"Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis","volume":"12","author":"Fowler","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.11825","article-title":"Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: The CITRIS-ALI randomized clinical trial","volume":"322","author":"Fowler","year":"2019","journal-title":"JAMA"},{"key":"ref_9","first-page":"212","article-title":"The clinical effects of vitamin C supplementation in elderly hospitalised patients with acute respiratory infections","volume":"64","author":"Hunt","year":"1994","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"ref_10","first-page":"17","article-title":"Ascorbic acid in the complex therapy of acute pneumonia","volume":"9","author":"Mochalkin","year":"1970","journal-title":"Voen. Med. Zhurnal"},{"key":"ref_11","unstructured":"Chen, Q., and Vissers, M. (2020). Vitamin C in pneumonia and sepsis. Vitamin C: New Biochemical and Functional Insights. Oxidative Stress and Disease, CRC Press\/Taylor & Francis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"590853","DOI":"10.3389\/fmed.2020.590853","article-title":"Reanalysis of the effect of vitamin C on mortality in the CITRIS-ALI trial: Important findings dismissed in the trial report","volume":"7","author":"Chalker","year":"2020","journal-title":"Front. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kashiouris, M.G., L\u2019Heureux, M., Cable, C.A., Fisher, B.J., Leichtle, S.W., and Fowler, A.A. (2020). The emerging role of vitamin C as a treatment for sepsis. Nutrients, 12.","DOI":"10.3390\/nu12020292"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Liu","year":"2020","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Auto-antibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4110\/in.2013.13.2.70","article-title":"Vitamin C is an essential factor on the anti-viral immune responses through the production of interferon-\u03b1\/\u03b2 at the initial stage of influenza A virus (H3N2) infection","volume":"13","author":"Kim","year":"2013","journal-title":"Immune Netw."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000136908","article-title":"Effect of ascorbic acid, sodium salicylate, and caffeine on the serum interferon level in response to viral infection","volume":"13","author":"Geber","year":"1975","journal-title":"Pharmacology"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zhang, J., Rao, X., Li, Y., Zhu, Y., Liu, F., Guo, G., Luo, G., Meng, Z., De Backer, D., and Xiang, H. (2020). High-dose vitamin C infusion for the treatment of critically ill COVID-19. Res. Sq.","DOI":"10.21203\/rs.3.rs-52778\/v1"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"200240","DOI":"10.1183\/16000617.0240-2020","article-title":"Targeting coagulation activation in severe COVID-19 pneumonia: Lessons from bacterial pneumonia and sepsis","volume":"29","author":"Williams","year":"2020","journal-title":"Eur. Respir. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Tyml, K. (2017). Vitamin C and microvascular dysfunction in systemic inflammation. Antioxidants, 6.","DOI":"10.3390\/antiox6030049"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Hiedra, R., Lo, K.B., Elbashabsheh, M., Gul, F., Wright, R.M., Albano, J., Azmaiparashvili, Z., and Patarroyo Aponte, G. (2020). The use of IV vitamin C for patients with COVID-19: A case series. Expert Rev. Anti Infect. Ther., 1\u20133.","DOI":"10.1080\/14787210.2020.1794819"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Skendros, P., Mitsios, A., Chrysanthopoulou, A., Mastellos, D.C., Metallidis, S., Rafailidis, P., Ntinopoulou, M., Sertaridou, E., Tsironidou, V., and Tsigalou, C. (2020). Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J. Clin. Investig.","DOI":"10.1101\/2020.06.15.20131029"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.3390\/nu5083131","article-title":"Vitamin C: A novel regulator of neutrophil extracellular trap formation","volume":"5","author":"Mohammed","year":"2013","journal-title":"Nutrients"},{"key":"ref_27","first-page":"A2100","article-title":"Effects of high dose intravenous vitamin C (IVC) on plasma cell-free DNA levels in patients with sepsis-associated ARDS","volume":"201","author":"Qiao","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"100741","DOI":"10.1016\/j.jbior.2020.100741","article-title":"Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression","volume":"77","author":"Raftery","year":"2020","journal-title":"Adv. Biol. Regul."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41577-020-0407-1","article-title":"Tissue damage from neutrophil-induced oxidative stress in COVID-19","volume":"20","author":"Laforge","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Carr, A.C., Spencer, E., Mackle, D., Hunt, A., Judd, H., Mehrtens, J., Parker, K., Stockwell, Z., Gale, C., and Beaumont, M. (2020). The effect of conservative oxygen therapy on systemic biomarkers of oxidative stress in critically ill patients. Free Radic. Biol. Med., under consideration.","DOI":"10.1016\/j.freeradbiomed.2020.06.018"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Carr, A.C., Spencer, E., Dixon, L., and Chambers, S.T. (2020). Patients with community acquired pneumonia exhibit depleted vitamin C status and elevated oxidative stress. Nutrients, 12.","DOI":"10.20944\/preprints202004.0243.v1"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0891-5849(97)00059-2","article-title":"The effects of intravenous antioxidants in patients with septic shock","volume":"23","author":"Galley","year":"1997","journal-title":"Free Radic. Biol. Med."},{"key":"ref_33","first-page":"S153","article-title":"Antioxidant therapy and survival in ARDS","volume":"17","author":"Sawyer","year":"1989","journal-title":"Crit. Care Med."},{"key":"ref_34","unstructured":"World Health Organization (2020). A Coordinated Global Research Roadmap: 2019 Novel Coronavirus, World Health Organization."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40560-020-0432-y","article-title":"Vitamin C may reduce the duration of mechanical ventilation in critically ill patients: A meta-regression analysis","volume":"8","author":"Hemila","year":"2020","journal-title":"J. Intensive Care"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Hemila, H., and Chalker, E. (2019). Vitamin C can shorten the length of stay in the ICU: A meta-analysis. Nutrients, 11.","DOI":"10.3390\/nu11040708"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13054-020-02890-x","article-title":"Managing COVID-19 in resource-limited settings: Critical care considerations","volume":"24","author":"Siow","year":"2020","journal-title":"Crit. Care"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Rowe, S., and Carr, A.C. (2020). Global vitamin C status and prevalence of deficiency: A cause for concern?. Nutrients, 12.","DOI":"10.3390\/nu12072008"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Carr, A.C., and Rowe, S. (2020). Factors affecting vitamin C status and prevalence of deficiency: A global health perspective. Nutrients, 12.","DOI":"10.3390\/nu12071963"},{"key":"ref_40","unstructured":"Centres for Disease Control and Prevention (2020, September 05). Assessing Risk Factors for Severe COVID-19 Illness 2020, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/covid-data\/investigations-discovery\/assessing-risk-factors.html."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s13054-020-03085-0","article-title":"Micronutrient status of COVID-19 patients: A critical consideration","volume":"24","author":"Carr","year":"2020","journal-title":"Crit. Care"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"101532","DOI":"10.1016\/j.redox.2020.101532","article-title":"On the effect of vitamin C intake on human health: How to (mis)interprete the clinical evidence","volume":"34","author":"Lykkesfeldt","year":"2020","journal-title":"Redox Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"100064","DOI":"10.1016\/j.medidd.2020.100064","article-title":"Serum levels of vitamin C and vitamin D in a cohort of critically ill COVID-19 patients of a north American community hospital intensive care unit in may 2020. A pilot study","volume":"8","author":"Arvinte","year":"2020","journal-title":"Med. Drug Discov."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s13054-020-03249-y","article-title":"Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome","volume":"24","author":"Roca","year":"2020","journal-title":"Crit. Care"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Pullar, J.M., Bayer, S., and Carr, A.C. (2018). Appropriate handling, processing and analysis of blood samples is essential to avoid oxidation of vitamin C to dehydroascorbic acid. Antioxidants, 7.","DOI":"10.3390\/antiox7020029"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e039519","DOI":"10.1136\/bmjopen-2020-039519","article-title":"Intravenous high-dose vitamin C for the treatment of severe COVID-19: Study protocol for a multicentre randomised controlled trial","volume":"10","author":"Liu","year":"2020","journal-title":"BMJ Open"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Hemil\u00e4, H., and Suonsyrj\u00e4, T. (2017). Vitamin C for preventing atrial fibrillation in high risk patients: A systematic review and meta-analysis. BMC Cardiovasc. Disord., 17.","DOI":"10.1186\/s12872-017-0478-5"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/11\/3286\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:29:07Z","timestamp":1760178547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/11\/3286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["nu12113286"],"URL":"https:\/\/doi.org\/10.3390\/nu12113286","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]}}}